Skip to main content

Cour Pharmaceutical Development Company Inc.

Founded: 2013

Northwestern Inventor:
Stephen Miller
Feinberg School of Medicine
Department of Microbiology-Immunology

Lonnie Shea
McCormick School of Engineering (formerly)
Department of Biomedical Engineering

Cour Pharmaceutical Development Company Inc., a private development stage biopharmaceutical company, was founded to develop innovative nanobiological therapeutics for acute inflammation, autoimmune and allergic conditions. Cour combines world-recognized leadership in pharmaceutical development, immunology, pathology and cardiovascular medicine with unprecedented in-house expertise in nanobiology and polymer chemistry. In November 2013, Cour entered into evaluation and option alliances with two major pharmaceutical companies to develop Cour products for Type 1 Diabetes and Celiac Disease respectively.

Twitter: @CourPharma

Cour Pharmaceutical Development Company Inc. Website